SEARCH

SEARCH BY CITATION

References

  • 1
    De Franchis R, Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768.
  • 2
    García-Tsao G, Bosch J, Groszmann R. Portal hypertension and variceal bleeding—unresolved issues. Summary of an American Association for the Study of Liver Diseases and European Association for the Study of the Liver single-topic conference. HEPATOLOGY 2008; 47: 1764-1772.
  • 3
    García-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010; 362: 823-832.
  • 4
    Bosch J, Abraldes JG, Berzigotti A, García-Pagán JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009; 6: 573-582.
  • 5
    D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006; 131: 1611-1624.
  • 6
    Albillos A, Bañares R, Gonzalez M, Ripoll C, Gonzalez R, Catalina MV, et al. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Am J Gastroenterol 2007; 102: 1116-1126.
    Direct Link:
  • 7
    Thalheimer U, Mela M, Patch D, Burroughs AK. Targeting portal pressure measurements: a critical reappraisal. HEPATOLOGY 2004; 39: 286-290.
  • 8
    Thalheimer U, Mela M, Patch D, Burroughs AK. Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence. Gut 2004; 53: 143-148.
  • 9
    Villanueva C, López-Balaguer JM, Aracil C, Kolle L, González B, Miñana J, et al. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J Hepatol 2004; 40: 757-765.
  • 10
    Merkel C, Bolognesi M, Berzigotti A, Amodio P, Cavasin L, Casarotto IM, et al. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria. J Hepatol 2010; 52: 45-53.
  • 11
    von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
  • 12
    González A, Augustin S, Pérez M, Dot J, Saperas E, Tomasello A, et al. Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study. HEPATOLOGY 2006; 44: 806-812.
  • 13
    González A, Augustin S, Dot J, Perez M, Abu-Suboh M, Romero A, et al. Adding banding ligation is effective as rescue therapy to prevent variceal rebleeding in hemodynamic non-responders to pharmacological therapy. Dig Liv Dis 2012; 44: 55-60.
  • 14
    De Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W, et al. Definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 1992; 15: 256-261.
  • 15
    De Franchis. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-176.
  • 16
    Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer 2004; 91: 1229-1235.
  • 17
    Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ. Deaths on the liver transplant waiting list: an analysis of competing risks. HEPATOLOGY 2006; 43: 345-351.
  • 18
    Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1140-1154.
  • 19
    van Leeuwen DJ, Howe SC, Scheuer PJ, Sherlock S. Portal hypertension in chronic hepatitis: relationship to morphological changes. Gut 1990; 31: 339-343.
  • 20
    Vorobioff J, Groszmann RJ, Picabea E, Gamen M, Villavicencio R, Bordato J, et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 1996; 111: 701-709.
  • 21
    Luca A, García-Pagán JC, Bosch J, Feu F, Caballeria J, Groszmann RJ, et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997; 112: 1284-1289.
  • 22
    Dell'Era A, Cubero Sotela J, Fabris FM, Petazzi G, Reati R, Iannuzzi F, et al. Primary prophylaxis of variceal bleeding in cirrhotic patients: a cohort study. Dig Liver Dis 2008; 40: 936-943.
  • 23
    Garcia-Pagan JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362: 2370-2379.